Auro Laboratories Ltd.
Snapshot View

79.90 +3.35 ▲4.4%

16 August 2022, 04:01:00 PM
Volume: 2,314

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.aurolabs.com
Market Cap 49.64 Cr.
Enterprise Value(EV) 49.09 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 2.99 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 26.67 Trailing Twelve Months Ending 2022-06
Industry PE 32.02 Trailing Twelve Months Ending 2022-06
Book Value / Share 50.71 Trailing Twelve Months Ending 2022-06
Price to Book Value 1.57 Calculated using Price: 79.65
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.62 Cr. 6,232,500 Shares
FaceValue 10
Company Profile
Auro Laboratories incorporated in 1989 is engaged in business of manufacturing active pharmaceutical ingredients (API's), intermediates and generic formulations. The company is promoted by Shri Sharat Deorah and Shri Satish Deorah.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+4.38%
1 Week
+2.17%
1 Month
-11.91%
3 Month
-15.32%
6 Month
-19.37%
1 Year
-38.35%
2 Year
+67.68%
5 Year
+27.13%
10 Year
+1309.17%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 8.76 11.01 10.83 9.06 31.53 28.95 20.84 28.67 9.47
Return on Capital Employed (%) 9.40 10.76 11.21 20.24 28.65 29.12 24.80 38.88 12.20
Return on Assets (%) 2.04 2.89 3.24 3.11 12.34 13.78 12.32 19.34 5.87

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 6 7 8 9 9 13 17 22 29 32
Non Curr. Liab. 8 7 8 7 11 8 6 5 4 3
Curr. Liab. 15 13 14 10 6 10 10 6 9 20
Minority Int.
Equity & Liab. 30 27 29 26 27 30 33 32 42 55
Non Curr. Assets 11 11 11 13 13 15 15 14 14 18
Curr. Assets 19 16 18 12 14 16 19 18 28 37
Misc. Exp. not W/O
Total Assets 30 27 29 26 27 30 33 32 42 55

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 34 33 28 35 41 47 44 54 51 52
Other Income 0 0 0 1 1 1 1 1 1 1
Total Income 34 33 28 36 41 48 45 55 52 52
Total Expenditure -31 -30 -25 -31 -34 -40 -38 -43 -46 -48
PBIDT 3 3 3 5 7 8 7 12 6 4
Interest -2 -2 -2 -1 -1 -1 -1 0 -1 -1
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Taxation -2 -1 -2 -2 -3 -1 -1
Exceptional Items
PAT 1 1 1 1 4 4 4 7 3 2
Adjusted EPS 1 1 1 1 6 7 7 12 5 3

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 1 4 -1 8 6 5 7 9 13 -7
Cash Fr. Inv. -1 -1 -1 -2 -2 -2 -3 -2 -4 -5
Cash Fr. Finan. -1 -3 1 -5 -4 -2 -2 -6 0 10
Net Change 0 1 -1 0 0 1 2 2 9 -2
Cash & Cash Eqvt 0 1 0 1 1 2 4 6 15 12

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 51.92 51.92 51.92 51.92 51.92 51.93 51.99 51.99 52.09
Public 48.08 48.08 48.08 48.08 48.08 48.07 48.01 48.01 47.91
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 03 Aug 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
With reference to Regulation 47 of SEBI [Listing Obligations and Disclosure Requirements] Regulation 2015 (Listing Regulations) we are enclosing herewith Newspaper cuttings of unaudited Financial Results of the Company for the quarter ended June 30 2022 published in the following Newspaper:1. Active Times Mumbai (i.e English Newspaper) dated August 03 20222. Mumbai Lakshdeep (i.e Marathi Newspaper) dated August 03 2022
Tue, 02 Aug 2022
Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended June 30 2022
Pursuant to Regulation 30 & Regulation 33 of SEBI (LODR) Regulations 2015 we wish to inform you that the Board of Directors of the Company at their Meeting held today (i.e. Tuesday August 02 2022) transacted the following business:

1. Considered and approved the Unaudited Financial Results of the Company for the quarter ended on June 30 2022 as recommended by the Audit Committee.
In this regard we are enclosing herewith:
Unaudited Financial Results for the quarter ended on June 30 2022
Limited Review Report received from the Statutory Auditors of the Company
Fri, 22 Jul 2022
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations 2015)
Auro Laboratories Ltd has informed BSE regarding the details of Voting results of AGM under Regulation 44(3) of SEBI (LODR) Regulations 2015. Kindly Click here

Technical Scans View Details >>

Fri, 12 Aug 2022
High Delivery Percentage High Delivery Percentage
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease 1 Month High Decrease 1 Month
High Decrease 3 Months High Decrease 3 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,167.25 914.60 +0.1%
Divi's Laboratories Ltd. 98,918.90 3,732.00 +0.2%
Cipla Ltd. 82,906.37 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. 70,920.35 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. 62,010.73 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. 51,917.53 1,569.90 +2.0%
Piramal Enterprises Ltd. 45,855.65 1,926.70 +0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.35 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 33.43 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-06 33.32 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.69 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.15 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.82 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-06 24.38 1,926.70 +0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.37 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8.44 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-06 3.86 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.50 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.43 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.12 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,926.70 +0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,926.70 +0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,926.70 +0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,926.70 +0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,926.70 +0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,926.70 +0.3%

FAQ's On Auro Laboratories Ltd.

Can I Buy Auro Laboratories Shares now?

What is the Share Price of Auro Laboratories?

What is the Relative Strength Index (RSI) Value of Auro Laboratories?

What is the Market Capital (MCAP) of Auro Laboratories?

What are the key metrics to analyse Auro Laboratories?

What is the Price Performance of Auro Laboratories?